The company has received final approval for six ANDAs (abbreviated new
drug application) and launched four products in the fourth quarter of
last fiscal.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-plans-to-launch-50-60-products-in-us-in-fy21/articleshow/76509828.cms
No comments:
Post a Comment